These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Associations between plasma ceramides and mortality in patients with coronary artery disease. Li Q; Wang X; Pang J; Zhang Y; Zhang H; Xu Z; Chen Q; Ling W Atherosclerosis; 2020 Dec; 314():77-83. PubMed ID: 32980131 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between lipid metabolism molecules in plasma and carotid atheroscle-rotic plaques, traditional cardiovascular risk factors, and dietary factors]. He J; Fang Z; Yang Y; Liu J; Ma W; Huo Y; Gao W; Wu Y; Xie G Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):722-728. PubMed ID: 39041571 [TBL] [Abstract][Full Text] [Related]
5. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification. Hilvo M; Vasile VC; Donato LJ; Hurme R; Laaksonen R Front Endocrinol (Lausanne); 2020; 11():570628. PubMed ID: 33133018 [TBL] [Abstract][Full Text] [Related]
6. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. Peterson LR; Xanthakis V; Duncan MS; Gross S; Friedrich N; Völzke H; Felix SB; Jiang H; Sidhu R; Nauck M; Jiang X; Ory DS; Dörr M; Vasan RS; Schaffer JE J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728014 [TBL] [Abstract][Full Text] [Related]
7. The Association Between C24:0/C16:0 Ceramide Ratio and Cardiorespiratory Fitness is Robust to Effect Modifications by Age and Sex. Zatloukal J; Zylla S; Markus MRP; Ewert R; Gläser S; Völzke H; Albrecht D; Friedrich N; Nauck M; Peterson LR; Jiang X; Schaffer JE; Felix SB; Dörr M; Bahls M; Gross S Adv Biol (Weinh); 2024 Apr; 8(4):e2300633. PubMed ID: 38342586 [TBL] [Abstract][Full Text] [Related]
8. Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies. McGurk KA; Keavney BD; Nicolaou A Atherosclerosis; 2021 Jun; 327():18-30. PubMed ID: 34004484 [TBL] [Abstract][Full Text] [Related]
9. Ceramides as Emerging Players in Cardiovascular Disease: Focus on Their Pathogenetic Effects and Regulation by Diet. Spaggiari R; Angelini S; Di Vincenzo A; Scaglione G; Morrone S; Finello V; Fagioli S; Castaldo F; Sanz JM; Sergi D; Passaro A Adv Nutr; 2024 Jul; 15(7):100252. PubMed ID: 38876397 [TBL] [Abstract][Full Text] [Related]
10. Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential. Zietzer A; Düsing P; Reese L; Nickenig G; Jansen F Arterioscler Thromb Vasc Biol; 2022 Oct; 42(10):1220-1228. PubMed ID: 36004640 [TBL] [Abstract][Full Text] [Related]
11. Links between ceramides and cardiac function. Park LK; Garr Barry V; Hong J; Heebink J; Sah R; Peterson LR Curr Opin Lipidol; 2022 Feb; 33(1):47-56. PubMed ID: 34889803 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Hilvo M; Meikle PJ; Pedersen ER; Tell GS; Dhar I; Brenner H; Schöttker B; Lääperi M; Kauhanen D; Koistinen KM; Jylhä A; Huynh K; Mellett NA; Tonkin AM; Sullivan DR; Simes J; Nestel P; Koenig W; Rothenbacher D; Nygård O; Laaksonen R Eur Heart J; 2020 Jan; 41(3):371-380. PubMed ID: 31209498 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of ceramides relate to ischemic stroke risk and clinical severity. Gui YK; Li Q; Liu L; Zeng P; Ren RF; Guo ZF; Wang GH; Song JG; Zhang P Brain Res Bull; 2020 May; 158():122-127. PubMed ID: 32165273 [TBL] [Abstract][Full Text] [Related]
14. Ceramides: a potential cardiovascular biomarker in young adult childhood cancer survivors? Broberg O; Weismann CG; Øra I; Wiebe T; Laaksonen R; Liuba P Eur Heart J Open; 2024 Mar; 4(2):oeae026. PubMed ID: 38659666 [TBL] [Abstract][Full Text] [Related]
15. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy. Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175 [TBL] [Abstract][Full Text] [Related]
16. Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography. Pan W; Dong H; Sun R; Zhao L; Sun M; Li L; Yu X; Liu J; Wu J; Yang F; Yu B J Cardiovasc Transl Res; 2021 Feb; 14(1):140-149. PubMed ID: 32212040 [TBL] [Abstract][Full Text] [Related]
17. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy. Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Canali G; Byrne CD; Gori S; Barbieri E; Targher G Metabolism; 2018 Aug; 85():305-312. PubMed ID: 29777715 [TBL] [Abstract][Full Text] [Related]
18. Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology. Wittenbecher C; Cuadrat R; Johnston L; Eichelmann F; Jäger S; Kuxhaus O; Prada M; Del Greco M F; Hicks AA; Hoffman P; Krumsiek J; Hu FB; Schulze MB Nat Commun; 2022 Feb; 13(1):936. PubMed ID: 35177612 [TBL] [Abstract][Full Text] [Related]